$EXEL Company News Biotechs still sliding, but Wall

New Post Public Reply Private Reply Replies (0) Message Board

May 1, 2014 at 9:30 AM

$EXEL Company News

Biotechs still sliding, but Wall Street says don't hit panic button just yet 2:43 p.m. March 26, 2014 - Russ Britt
HMA’s pre-emptive strike against ‘60 Minutes’ 5:44 p.m. Nov. 30, 2012 - Russ Britt
Chipotle vs. Taco Bell: testing Einhorn's thesis 6:37 a.m. Oct. 4, 2012 - The Trading Deck
Exelixis prices stock offering at 0.7% discount 12:21 p.m. Aug. 9, 2012 - MarketWatch.com
Exelixis slides 12% on stock, debt offering 3:39 p.m. Aug. 6, 2012 - Val Brickates Kennedy
FDA to speed Exelixis thyroid-cancer-drug review 6:35 a.m. July 30, 2012 - MarketWatch.com
Stocks to watch Thursday: GM, Agilent, NetApp 7:51 a.m. Feb. 16, 2012 - MarketWatch
Exelixis licenses cancer-drug R&D to Merck & Co. 8:26 a.m. Dec. 21, 2011 - MarketWatch.com
Loathe that investment theme? Perfect! 1:03 p.m. Nov. 8, 2011 - The Trading Deck
Exelixis plunges on drug study woes 12:05 p.m. Nov. 1, 2011 - Val Brickates Kennedy
Stocks to watch Tuesday: Exelixis, DirecTV, Leap 6:46 a.m. Nov. 1, 2011 - MarketWatch
Exelixis slides, Allstate up in after-hours trade 6:48 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis shares fall without FDA study commentary 6:05 p.m. Oct. 31, 2011 - Wallace Witkowski
Exelixis shares resume trading, drop 35% 5:44 p.m. Oct. 31, 2011 - Carla Mozee
Exelixis rallies 21% on drug study 11:46 a.m. Oct. 24, 2011 - Val Brickates Kennedy
Icahn reports new stakes in Vector Group, El Paso 7:52 p.m. Aug. 15, 2011 - MarketWatch.com
ASCO studies shake up drug stocks 4:17 p.m. June 7, 2011 - Val Brickates Kennedy
Monday’s biggest gaining and declining stocks 6:50 p.m. June 6, 2011 - Kate Gibson
Exelixis, Sunesis lead drug stocks lower 3:42 p.m. June 6, 2011 - Val Brickates Kennedy
Exelixis sinks 18% on drug-safety concerns 3:21 p.m. June 6, 2011 - Val Brickates Kennedy

Notable earnings after Thursday close 5:35 p.m. April 30, 2014 - Seeking Alpha
First Week Of June 21st Options Trading For Exelixis (EXEL) 11:19 a.m. April 23, 2014 - TheStreet.com
Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog 10:43 a.m. April 2, 2014 - Zacks.com
Exelixis' Cometriq Approved in the EU - Analyst Blog 6:00 p.m. March 27, 2014 - Zacks.com
Trade-Ideas: Exelixis (EXEL) Is Today's "Dead Cat Bounce" Stock 9:45 a.m. March 27, 2014 - TheStreet.com
Interesting EXEL Put And Call Options For November 22nd 12:13 p.m. March 26, 2014 - TheStreet.com
Disappointment Over Prostate Cancer Drug Study Weigh Heavily on Exelixis 11:42 a.m. March 26, 2014 - TheStreet.com
Exelixis Enters the Danger Zone 11:35 a.m. March 26, 2014 - 247WallSt.com
Mid-Day Market Update: Five Below Jumps On Upbeat Results; Exelixis Shares Decline 11:28 a.m. March 26, 2014 - benzinga.com
Exelixis Urged to Continue Studying Prostate Cancer Treatment 9:27 a.m. March 26, 2014 - The Wall Street Journal Interactive Edition
Mid-Morning Market Update: Markets Open Higher; Francesca's Issues Downbeat Q1 Forecast 9:24 a.m. March 26, 2014 - benzinga.com
Stocks Hitting 52-Week Lows 9:22 a.m. March 26, 2014 - benzinga.com
Exelixis (EXEL) Trading With Heavy Volume Before Market Open 8:46 a.m. March 26, 2014 - TheStreet.com
Exelixis trial for prostate-cancer drug given OK to continue 7:37 a.m. March 26, 2014 - Seeking Alpha
4 Reasons To Be Bullish On Exelixis In The Near Term 10:11 a.m. March 25, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I Want to Buy Time Warner 6:00 a.m. March 14, 2014 - TheStreet.com
Cramer's Lightning Round - I Don't Know What Annaly Is Up To (3/13/14) 5:23 a.m. March 14, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Us vs. Them 7:58 p.m. March 13, 2014 - TheStreet.com
Exelixis Q4 Loss In Line with Expectations - Analyst Blog 12:04 p.m. Feb. 21, 2014 - Zacks.com
Exelixis CEO Discusses Q4 2013 Results - Earnings Call Transcript 11:37 p.m. Feb. 20, 2014 - Seeking Alpha

The World Market for Orphan Drugs 6:59 p.m. April 29, 2014 - PR Newswire - PRF
Exelixis to Release First Quarter 2014 Financial Results on Thursday, May 1, 2014 4:07 p.m. April 21, 2014 - BusinessWire - BZX
Thyroid Cancer Global Clinical Trials Review, H2, 2013 1:29 p.m. April 9, 2014 - PR Newswire - PRF
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer 2:01 p.m. April 4, 2014 - ACCESSWIRE
King Digital Crushed In Its First Day of Trading; Exelixis Shares Fall 40 Percent 12:11 a.m. March 27, 2014 - ACCESSWIRE
Exelixis Provides Update on Ongoing COMET-1 Phase 3 Pivotal Trial in Men with Metastatic Castration-Resistant Prostate Cancer 7:18 p.m. March 25, 2014 - BusinessWire - BZX
Cometriq(R) approved in Europe for the treatment of progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma. 7:02 a.m. March 25, 2014 - Thomson Reuters ONE
Exelixis Receives Approval for COMETRIQ® (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma 6:01 a.m. March 25, 2014 - BusinessWire - BZX
Pre-Market Pulse - Health Care Sector Stocks -- Research on Exelixis, StemCells, Dendreon, and Vivus 10:46 a.m. March 24, 2014 - PR Newswire - PRF
Exelixis Announces Webcast of March 4 Presentation at the 34th Annual Cowen and Company Health Care Conference 8:56 p.m. Feb. 26, 2014 - BusinessWire - BZX
Exelixis Announces Fourth Quarter and Full Year 2013 Financial Results 5:15 p.m. Feb. 20, 2014 - BusinessWire - BZX
Exelixis Appoints Executive Vice President and General Counsel 6:27 p.m. Feb. 12, 2014 - BusinessWire - BZX
Exelixis Announces February 20th Webcast of Fourth Quarter and Full Year 2013 Financial Results Conference Call 5:35 p.m. Feb. 10, 2014 - BusinessWire - BZX
Exelixis Announces Webcasts of Investor Conference Presentations in February 6:48 p.m. Jan. 31, 2014 - BusinessWire - BZX
Exelixis Announces Pricing of Overnight Offering of 10,000,000 Shares of Common Stock 9:33 a.m. Jan. 23, 2014 - BusinessWire - BZX
Exelixis Launches Proposed Overnight Public Offering of Common Stock 5:01 p.m. Jan. 22, 2014 - BusinessWire - BZX
Honigman leads client to victory in U.S. Court of Appeals patent term adjustment ruling 8:08 a.m. Jan. 17, 2014 - GlobeNewswire
Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine 9:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
Upcoming Conference Participations, Cash Dividends, and Share Price Movements - Research Report on Johnson & Johnson, Boston Scientific, NuVasive, Exelixis, and Healthways 9:00 a.m. Jan. 7, 2014 - PR Newswire
Clinical Study Results, Pending Applications, Trial Updates, and Discontinued Trials - Research Report on ICU Medical, Exelixis, Cempra, Exact Sciences, and Onconova 9:00 a.m. Dec. 25, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

D-Wave's Legal Trouble: Securities Fraud Suit Looms

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Intelligent Communication Forum Eyes Global Ecosystem Shift

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Historic Records Set at 2026 CNO Monumental Marathon

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

ASTS Faces Class Action; Investors Beware of Pitfalls

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Quantum Space Joins $185M NASA Lunar Transport Deal

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

MWC26 Doha: Bridging Standards for MENA's Future

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

2027 Toy of the Year Finalists Energize Play Market

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...